Filing Details
- Accession Number:
- 0000899243-16-029278
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-19 17:57:45
- Reporting Period:
- 2016-09-15
- Filing Date:
- 2016-09-19
- Accepted Time:
- 2016-09-19 17:57:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1393020 | Invuity Inc. | IVTY | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1576244 | W Eric Roberts | C/O Invuity, Inc. 444 De Haro Street San Francisco CA 94107 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-09-15 | 5,000 | $13.47 | 252,833 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 69,945 | Direct |
Footnotes
- The shares were sold pursuant to the Rule 10b5-1 trading plan entered into by Valence CDK SPV, L.P. ("Valence CDK") on December 1, 2015.
- This transaction was executed in multiple trades at prices ranging from $13.02 to $13.64. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The shares are held by Valence CDK. Valence Life Sciences GP II, LLC ("Valence") is the General Partner of Valence CDK. The Reporting Person is a Managing Member of Valence and disclaims beneficial ownership of the shares held by Valence CDK, except to the extent of his pecuniary interest therein.